Concordia receives $5.1M investment in genome engineering

November 26, 2020
Concordia University has received $5.1M from Genome Canada, Genome Quebec, and the National Research Council to support research in the synthetic biology field. “These contributions speak to Concordia’s influence and leadership in synthetic biology,” said Paula Wood-Adams, Concordia’s interim VP of research and graduate studies. “They provide our researchers with resources and promising new technologies ensuring that their work will lead to breakthroughs in health care and other essential areas.” A project at Concordia’s Centre for Applied Synthetic Biology will receive $1.95M over the next three years through Genome Canada’s Genomic Applications Partnership Program (GAPP). Concordia (QC)